Literature DB >> 18755354

Pharmacological differences of glitazones: does peroxisome proliferator-activated receptor-alpha activation make the difference?

Ulrich Kintscher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755354     DOI: 10.1016/j.jacc.2008.06.012

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects.

Authors:  Shipra Agrawal; Adam J Guess; Rainer Benndorf; William E Smoyer
Journal:  Mol Pharmacol       Date:  2011-06-02       Impact factor: 4.436

Review 2.  From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options.

Authors:  Amalia Gastaldelli; Kenneth Cusi
Journal:  JHEP Rep       Date:  2019-07-19

3.  Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

Authors:  Ioanna Tzoulaki; Mariam Molokhia; Vasa Curcin; Mark P Little; Christopher J Millett; Anthea Ng; Robert I Hughes; Kamlesh Khunti; Martin R Wilkins; Azeem Majeed; Paul Elliott
Journal:  BMJ       Date:  2009-12-03

4.  A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro.

Authors:  Henry Querfurth; John Marshall; Keykavous Parang; Mengia S Rioult-Pedotti; Rakesh Tiwari; Bumsup Kwon; Steve Reisinger; Han-Kyu Lee
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

Review 5.  The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus.

Authors:  Isabella Bonilha; Eric Hajduch; Beatriz Luchiari; Wilson Nadruz; Wilfried Le Goff; Andrei C Sposito
Journal:  Metabolites       Date:  2021-11-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.